ConductScience.org, home

Paper23348993

Synthesis and structure-activity relationships of novel amino/nitro substituted 3-arylcoumarins as antibacterial agents.

Matos MJ and 6 others. Molecules, 2013. Cited by 38 papers, by iCite.

Cite this record

ConductScience Library. Synthesis and structure-activity relationships of novel amino/nitro substituted 3-arylcoumarins as antibacterial agents. Papers, record 23348993. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23348993

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Synthesis and structure-activity relationships of novel amino/nitro substituted 3-arylcoumarins as antibacterial agents.
PubMed
Journal
Molecules
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
38
iCite
Relative citation ratio, by iCite
1.53
iCite
Revised in PubMed
2021-10-21
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Matos MJMaria J
2Vazquez-Rodriguez SSaleta
3Santana LLourdes
4Uriarte EEugenio
5Fuentes-Edfuf CCristina
6Santos YYsabel
7Muñoz-Crego AAngeles

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AminesMajor topic
Anti-Bacterial AgentsMajor topic
CoumarinsMajor topic
Nitro CompoundsMajor topic
Dicumarol
Escherichia coli
Microbial Sensitivity Tests
Novobiocin
Staphylococcus aureus
Structure-Activity Relationship

Source PubMed

Download CSV of topics

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110450985Synthesis and in vitro evaluation of novel highly potent coumarin inhibitors of gyrase B.Bioorg Med Chem Lett1999https://conductscience.org/library/papers/10450985PubMed
217682095Discovery of novel DNA gyrase inhibitors by high-throughput virtual screening.Antimicrob Agents Chemother2007https://conductscience.org/library/papers/17682095PubMed
320630755Synthesis, selective anti-Helicobacter pylori activity, and cytotoxicity of novel N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides.Bioorg Med Chem Lett2010https://conductscience.org/library/papers/20630755PubMed
418251491Coumarin as attractive casein kinase 2 (CK2) inhibitor scaffold: an integrate approach to elucidate the putative binding motif and explain structure-activity relationships.J Med Chem2008https://conductscience.org/library/papers/18251491PubMed
56295263Effects of novobiocin, coumermycin A1, clorobiocin, and their analogs on Escherichia coli DNA gyrase and bacterial growth.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6295263PubMed
621316817Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives.Eur J Med Chem2011https://conductscience.org/library/papers/21316817PubMed
716881035Antibacterial natural products in medicinal chemistry--exodus or revival?Angew Chem Int Ed Engl2006https://conductscience.org/library/papers/16881035PubMed
817655212Extensive SAR and computational studies of 3-{4-[(benzylmethylamino)methyl]phenyl}-6,7-dimethoxy-2H-2-chromenone (AP2238) derivatives.J Med Chem2007https://conductscience.org/library/papers/17655212PubMed
921215620Synthesis and evaluation of a class of new coumarin triazole derivatives as potential antimicrobial agents.Bioorg Med Chem Lett2011https://conductscience.org/library/papers/21215620PubMed
1015496893Antibiotics at the crossroads.Nature2004https://conductscience.org/library/papers/15496893PubMed
1119628387Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors.Bioorg Med Chem Lett2009https://conductscience.org/library/papers/19628387PubMed
1222779756Looking for new targets: simple coumarins as antibacterial agents.Med Chem2012https://conductscience.org/library/papers/22779756PubMed
1311215328Antimicrobial activity of new coumarin derivatives.Arzneimittelforschung2001https://conductscience.org/library/papers/11215328PubMed
1421923181Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors.J Med Chem2011https://conductscience.org/library/papers/21923181PubMed
1521216502Synthesis of 4H-chromene, coumarin, 12H-chromeno[2,3-d]pyrimidine derivatives and some of their antimicrobial and cytotoxicity activities.Eur J Med Chem2011https://conductscience.org/library/papers/21216502PubMed
1619423346A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors.Bioorg Med Chem Lett2009https://conductscience.org/library/papers/19423346PubMed
1720409723Design, synthesis and anticancer activities of stilbene-coumarin hybrid compounds: Identification of novel proapoptotic agents.Bioorg Med Chem2010https://conductscience.org/library/papers/20409723PubMed
1920659799New halogenated 3-phenylcoumarins as potent and selective MAO-B inhibitors.Bioorg Med Chem Lett2010https://conductscience.org/library/papers/20659799PubMed
2018977661Synthesis and antimicrobial activity of 2-alkenylchroman-4-ones, 2-alkenylthiochroman-4-ones and 2-alkenylquinol-4-ones.Bioorg Med Chem2008https://conductscience.org/library/papers/18977661PubMed
2119633620Tyrosinase inhibitor activity of coumarin-resveratrol hybrids.Molecules2009https://conductscience.org/library/papers/19633620PubMed

See all 25 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.

PMIDTitleJournalYearIn PapersSource
40725260Advanced Research on Biological Properties-A Study on the Activity of the Apis mellifera Antioxidant System and the Crystallographic and Spectroscopic Properties of 7-Diethylamino-4-hydroxycoumarin.Int J Mol Sci2025https://conductscience.org/library/papers/40725260PubMed
40213246Synergistic effects of doxorubicin and coumarin on colorectal cancer cell proliferation and EMT modulation: in silico and in vitro study.Ann Med Surg (Lond)2025https://conductscience.org/library/papers/40213246PubMed
39665231Compounds Containing 2,3-Bis(phenylamino) Quinoxaline Exhibit Activity Against Methicillin-Resistant Staphylococcus aureus, Enterococcus faecalis, and Their Biofilms.Microbiologyopen2024https://conductscience.org/library/papers/39665231PubMed
36615454Design, Catalyst-Free Synthesis of New Novel α-Trifluoromethylated Tertiary Alcohols Bearing Coumarins as Potential Antifungal Agents.Molecules2022https://conductscience.org/library/papers/36615454PubMed
35821884Metal-free domino amination-Knoevenagel condensation approach to access new coumarins as potent nanomolar inhibitors of VEGFR-2 and EGFR.Green Chem Lett Rev2021https://conductscience.org/library/papers/35821884PubMed
35625352Filamentous Thermosensitive Mutant Z: An Appealing Target for Emerging Pathogens and a Trek on Its Natural Inhibitors.Biology (Basel)2022https://conductscience.org/library/papers/35625352PubMed
35438580Natural source, bioactivity and synthesis of 3-Arylcoumarin derivatives.J Enzyme Inhib Med Chem2022https://conductscience.org/library/papers/35438580PubMed
34946609Retrieval of High Added Value Natural Bioactive Coumarins from Mandarin Juice-Making Industrial Byproduct.Molecules2021https://conductscience.org/library/papers/34946609PubMed
347711643-Phenylcoumarins as a Privileged Scaffold in Medicinal Chemistry: The Landmarks of the Past Decade.Molecules2021https://conductscience.org/library/papers/34771164PubMed
33405018Analysis of Fluorescence Quenching of Coumarin Derivative under Steady State and Transient State Methods.J Fluoresc2021https://conductscience.org/library/papers/33405018PubMed
31375003Antibacterial Activity and Molecular Docking Studies of a Selected Series of Hydroxy-3-arylcoumarins.Molecules2019https://conductscience.org/library/papers/31375003PubMed
28617340Coumarin-Tetrapyrrolic Macrocycle Conjugates: Synthesis and Applications.Molecules2017https://conductscience.org/library/papers/28617340PubMed
24077176Synthesis and antibacterial evaluation of some novel imidazole and benzimidazole sulfonamides.Molecules2013https://conductscience.org/library/papers/24077176PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23348993

GET https://conductscience.org/api/papers/v1/23348993/references?page=2